Table 2.
Prevalence of each medication/drug class in the manual abstraction and automated extraction data. Data show the number of visits (out of the total 4,414) in which each medication was administered (inpatient medications) or an active prescription at the time of hospitalization (outpatient medications).
| Number of visits in which medication was administered during hospitalization |
Number of visits in which medication was actively prescribed at the time of hospitalization |
||||
|---|---|---|---|---|---|
| Inpatient | Manual | Automated | Outpatient | Manual | Automated |
| Hydroxychloroquine | 2656 | 2576 | Statin | 1323 | 1425 |
| Antibiotics | 2513 | 2138 | NSAID | 1021 | 1270 |
| Statins | 1115 | 986 | ACEi/ARB | 1090 | 1180 |
| NSAID | 878 | 698 | PPI | 624 | 619 |
| Vasopressors | 747 | 646 | Steroids | 360 | 595 |
| Diuretics | 706 | 275 | Immunosuppressives | 279 | 305 |
| Steroids | 697 | 880 | Hydroxychloroquine | 83 | 126 |
| ACEi/ARB | 334 | 267 | Antivirals | 69 | 148 |
| Remdesivir | 188 | 0 | Oseltamivir | 50 | 24 |
| Tocilizumab | 171 | 168 | |||
| Oseltamivir | 75 | 77 | |||
| Inotropes | 62 | 49 | |||
| Sarilumab | 27 | 0 | |||
| IVIG | 21 | 19 | |||
| Lopinavir/Ritonavir | 1 | 5 | |||
| Protease Inhibitors | 0 | 0 | |||